What are the requirements of USP for tablet form of oral dosage <1062>?
Chapter 1062, written as USP <1062>, TABLET COMPRESSION CHARACTERIZATION, provides guidelines for the tablet form of dosages. It also offers some insight into common problems during the compression process and how these can be solved.
June 14, 2023
by Muhammad Asim Niazi
Dr. Reddy's Laboratories Launches Valsartan Tablets, USP in the U.S. Market
Dr. Reddy’s Laboratories Ltd. announced the launch of Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan® (valsartan) Tablets approved by the U.S. Food and Drug Administration (USFDA).
December 10, 2021
by AmericanPharmaceuticalReview
Sagent Pharmaceuticals Recalls Levetiracetam Injection, USP Due to Lack of Sterility Assurance
Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product.
December 1, 2021
by AmericanPharmaceuticalReview
United States Pharmacopeia Acquires Pharmatech Associates
Expanded offerings will help regulated life science companies strengthen the supply chain for safe, quality medicines.
July 12, 2021
by contractpharma
USP to release <922> Water Activity method for pharma
The new chapter, to be released in May, highlights the benefits of water activity measurement, as well as potential applications and best practices for use in pharmaceutical manufacturing.
April 20, 2021
by europeanpharmaceuticalreview
Collaboration to encourage US adoption of continuous manufacturing
USP and Phlow have built a new laboratory to develop test methods and standards to facilitate broader adoption of continuous manufacturing in the US.
April 14, 2021
by europeanpharmaceuticalreview
Phlow Corp. and USP Form Alliance
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.
March 2, 2021
by contractpharma
USP Expands Alcohol-based Hand Sanitizer Support in Response to Quality Incidents
In response to the alcohol-based hand sanitizer quality incidents reported across the globe, the U.S. Pharmacopeia (USP) is offering free access to USP-NF standards, information and on-demand education related to producing quality alcohol-based hand ...
February 8, 2021
by americanpharmaceuticalreview
USP Launches Trust Accelerated Program to Help COVID-19 Treatment, Vaccine Development
To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
May 14, 2020
by americanpharmaceuticalreview
USP Offers Hand Sanitizer Toolkit in Response to COVID-19 Pandemic
The U.S. Pharmacopeia (USP) is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers by manufacturers, pharmacies and other facilities.
April 7, 2020
by americanpharmaceuticalreview
USP Offers Support for Developers of COVID-19 Antiviral Drugs and Vaccines
The U.S. Pharmacopeia (USP) is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
March 23, 2020
by americanpharmaceuticalreview
USP Offers Support for COVID-19 Antiviral/Vax Developers
Aims to help developers ensure quality of their materials as they scale up manufacturing to bring products into clinical development.
March 20, 2020
by contractpharma